Eli Lilly and Company (LLY) Stock Price, News, Quote & History - Yahoo Finance (2024)

0&&s)if(o){var r,a=(r=e.newCount)>99;s.textContent=a?"99+":r+"",null===(t=s.parentElement)||void 0===t||t.classList.add(zt)}else s.style.display="block"},f=function(){d.refreshPanel().then(h).then(ee).catch((function(){}))};e.addEventListener("close-all-menus",(function(){xe(c)||u()})),c&&(f(),setInterval((function(){f()}),3e5),o?l&&l.addEventListener("mouseenter",(function(){p(),null==t||t.show()})):c.addEventListener("mouseenter",(function(){p(),null==t||t.show()})),c.addEventListener("mouseleave",(function(){u(),null==t||t.hide()}))),e.addElementListener(i,"click",(function(){Q("ybar","notification","",{elm:"btn",elmt:"block"===(null==s?void 0:s.style.display)?"newalert":"",subsec:"notification",itc:"1"})})),r&&Ee(e,r,"ybar","notification",{elm:"expand",subsec:"notifications",itc:"2"}),e.addElementListener(a,"focusin",(function(){i&&(i.checked=!0),null==a||a.classList.add("ybarMenuOpen")})),e.addElementListener(a,"focusout",u),e.addElementListener(n.tooltipContainer,"focusin",(function(){null==t||t.show()})),e.addElementListener(n.tooltipContainer,"focusout",(function(){null==t||t.hide()}));var m=e.getConfig().device,v=document.getElementById("ybar");v&&v.classList.contains("ybar-ytheme-crunch")&&(eo=0);var y=new RegExp("[?&]notifications=1(&|#|$)");"desktop"===m&&i&&y.test(window.location.search)&&(i.checked=!0)};ye("ybar-mod-notification",(function(e){var n={isUH3:"crunch"===e.getConfig().ytheme,notifContainer:document.getElementById("notification-container"),notifBadge:document.getElementById("notif-badge"),notifMenu:document.getElementById("ybarNotificationMenu"),notifMenuOpener:document.querySelector("#ybarNotificationMenu + label"),notifDropdown:document.getElementById("notifDropdownContainer"),tooltipContainer:document.querySelector(".".concat(Gt)),notifLabel:document.querySelector(".".concat(Wt))};to(e,n)}))}()}};

NYSE - Nasdaq Real Time Price USD

Compare

885.01 +6.56 (+0.75%)

At close: 4:00 PM EDT

886.50 +1.49 (+0.17%)

After hours: 5:08 PM EDT

Line

Candle

Baseline

Mountain

Bar

Advanced Chart

Loading Chart for LLY

9/21 12:03 PM

DELL

Date
Close
Open
High
Low
Volume
  • Previous Close 878.45
  • Open 878.00
  • Bid 884.02 x 2200
  • Ask 888.00 x 900
  • Day's Range 876.86 - 892.20
  • 52 Week Range 434.34 - 892.20
  • Volume 2,503,177
  • Avg. Volume 2,590,179
  • Market Cap (intraday) 841.118B
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) 130.92
  • EPS (TTM) 6.76
  • Earnings Date Aug 8, 2024
  • Forward Dividend & Yield 5.20 (0.59%)
  • Ex-Dividend Date May 15, 2024
  • 1y Target Est 863.79

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

www.lilly.com

43,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - General

Industry

More about Eli Lilly and Company

Recent News: LLY

View More

All SEC Filings

Corporate Changes & Voting Matters

Periodic Financial Reports

Proxy Statements

Tender Offer/Acquisition Reports

Offering Registrations

View More

Performance Overview: LLY

Trailing total returns as of 6/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LLY

52.35%

S&P 500

14.75%

1-Year Return

LLY

99.15%

S&P 500

24.12%

3-Year Return

LLY

314.47%

S&P 500

29.58%

5-Year Return

LLY

752.06%

S&P 500

89.58%

Compare To: LLY

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

LLYEli Lilly and Company

885.01

+0.75%

Mkt Cap 841.118B

Industry Drug Manufacturers—General

PFEPfizer Inc.

26.98

-2.00%

Mkt Cap 152.885B

Industry Drug Manufacturers—General

ABBVAbbVie Inc.

169.68

+0.65%

Mkt Cap 299.633B

Industry Drug Manufacturers—General

127.50

-0.94%

Mkt Cap 322.933B

Industry Drug Manufacturers—General

145.95

+0.28%

Mkt Cap 351.255B

Industry Drug Manufacturers—General

BMYBristol-Myers Squibb Company

40.97

-0.56%

Mkt Cap 83.05B

Industry Drug Manufacturers—General

AZNAstraZeneca PLC

79.31

-0.35%

Mkt Cap 245.901B

Industry Drug Manufacturers—General

BIIBBiogen Inc.

226.46

-2.26%

Mkt Cap 32.972B

Industry Drug Manufacturers—General

AMGNAmgen Inc.

303.28

+1.56%

Mkt Cap 162.69B

Industry Drug Manufacturers—General

GILDGilead Sciences, Inc.

64.27

-1.21%

Mkt Cap 80.071B

Industry Drug Manufacturers—General

NVSNovartis AG

104.93

-0.75%

Mkt Cap 215.215B

Industry Drug Manufacturers—General

Statistics: LLY

View More

Valuation Measures

Annual

As of 6/14/2024

  • Market Cap

    834.88B

  • Enterprise Value

    858.51B

  • Trailing P/E

    129.37

  • Forward P/E

    64.10

  • PEG Ratio (5yr expected)

    2.60

  • Price/Sales (ttm)

    22.09

  • Price/Book (mrq)

    65.16

  • Enterprise Value/Revenue

    23.89

  • Enterprise Value/EBITDA

    88.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    17.08%

  • Return on Assets (ttm)

    12.60%

  • Return on Equity (ttm)

    50.75%

  • Revenue (ttm)

    35.93B

  • Net Income Avi to Common (ttm)

    6.14B

  • Diluted EPS (ttm)

    6.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.65B

  • Total Debt/Equity (mrq)

    204.28%

  • Levered Free Cash Flow (ttm)

    -1.23B

View More

Research Analysis: LLY

View More
View More

Company Insights: LLY

Research Reports: LLY

View More
View More

People Also Watch

BMY Bristol-Myers Squibb Company

40.97

-0.56%

MRK Merck & Co., Inc.

127.50

-0.94%

ABT Abbott Laboratories

103.45

-0.22%

AMGN Amgen Inc.

303.28

+1.56%

NVO Novo Nordisk A/S

140.37

-1.49%

JNJ Johnson & Johnson

145.95

+0.28%

ABBV AbbVie Inc.

169.68

+0.65%

PFE Pfizer Inc.

26.98

-2.00%

UNH UnitedHealth Group Incorporated

489.23

-1.17%

AZN AstraZeneca PLC

79.31

-0.35%

GSK GSK plc

40.66

+0.02%

AVGO Broadcom Inc.

1,828.87

+5.41%

NVS Novartis AG

104.93

-0.75%

MDT Medtronic plc

79.95

-1.35%

BIIB Biogen Inc.

226.46

-2.26%

GILD Gilead Sciences, Inc.

64.27

-1.21%

Eli Lilly and Company (LLY) Stock Price, News, Quote & History - Yahoo Finance (2024)
Top Articles
Latest Posts
Article information

Author: Greg Kuvalis

Last Updated:

Views: 5393

Rating: 4.4 / 5 (75 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Greg Kuvalis

Birthday: 1996-12-20

Address: 53157 Trantow Inlet, Townemouth, FL 92564-0267

Phone: +68218650356656

Job: IT Representative

Hobby: Knitting, Amateur radio, Skiing, Running, Mountain biking, Slacklining, Electronics

Introduction: My name is Greg Kuvalis, I am a witty, spotless, beautiful, charming, delightful, thankful, beautiful person who loves writing and wants to share my knowledge and understanding with you.